Finally, we also examined the activation and exhaustion of NK cells in PCa patients treated with WBM using flow cytometry and a panel of antibodies against CD56, TNFα, IFN‐γ, Granzyme B, TIGIT, and NKG2A. The gene discussed is KLRC1; the disease is posterior cortical atrophy.